John Kincaid - Concepedia

Author

John Kincaid

Also Known As

Cynthia Bodkin, J F KINCAID, J Kincaid, J. F. KINCAID, J. F. Kincaid, J. Kincaid, John F Kincaid, John F. Kincaid, John Kincaid, John W.R. Kincaid

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)Evotec (United States)Princeton University University of Illinois Chicago Indiana University – Purdue University Indianapolis

About

John Kincaid is an author at Alexion Pharmaceuticals (United States) specializing in medicine, pharmacology, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.9K
2	Engineering	13	15	1.3K
3	Natural Sciences	10	10	564
4	Health Sciences	3	3	142
5	Arts	1	1	12

John Kincaid

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Free Volumes and Free Angle Ratios of Molecules in Liquids John Kincaid, Henry Eyring The Journal of Chemical Physics EngineeringLiquid-liquid FlowFluid MechanicsExperimental ThermodynamicsSimple Liquid	1938	366
Novel <i>bis</i> -Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro Yasuhiro Koh, Hirotomo Nakata, Kenji Maeda, Antimicrobial Agents and Chemotherapy ImmunologyImmunotherapeuticsPharmacotherapyAntiviral DrugPharmaceutical Chemistry	2003	365
CRYSTALLINE POLYMERS OF METHYL METHACRYLATE Thomas Fox, B. S. Garrett, William E. Goode, Journal of the American Chemical Society Macromolecular ChemistryEngineeringAltmetric Attention ScoreOrganic ChemistryChemistry	1958	348
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, The Lancet Neurology	2019	216
Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere Arun K. Ghosh, John Kincaid, Wonhwa Cho, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapy	1998	154
Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment Johan Vande Walle, Yahsou Delmas, Gianluigi Ardissino, Journal of Nephrology	2016	134
Temperature dependence of the stereospecificity in the free radical polymerization of methyl methacrylate Thomas Fox, William E. Goode, Serge Gratch, Journal of Polymer Science Polymer ReactionEngineeringDepolymerizationRadical (Chemistry)Polymer Science	1958	127
Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of <i>N</i>-Aryl Cinnamides Elizabeth M. Doherty, Christopher Fotsch, Yunxin Bo, Journal of Medicinal Chemistry Transient Receptor PotentialMolecular PainPharmacotherapyMedicinal ChemistryVanilloid Receptor-1	2004	102
Nonpeptidal P<sub>2</sub> Ligands for HIV Protease Inhibitors: Structure-Based Design, Synthesis, and Biological Evaluation Arun K. Ghosh, John Kincaid, D. Eric Walters, Journal of Medicinal Chemistry	1996	96

Page 1